This is a demo store. No orders will be fulfilled.

Brazikumab (anti-IL-23) - Primary antibody, specific to IL23A, >95%, high purity, Human IgG2, INHIBITOR of Interleukin-23 inhibitor, INHIBITOR of Interleukin-23 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG2
  • Conjugation: Unconjugated
In stock
Item Number
Ab175478
Grouped product items
SKU Size
Availability
Price Qty
Ab175478-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$59.90
Ab175478-1mg
1mg
5
$279.90
Ab175478-5mg
5mg
1
$739.90
Ab175478-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,189.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Brazikumab (anti-IL-23) - Primary antibody, specific to IL23A, >95%, high purity, Human IgG2, INHIBITOR of Interleukin-23 inhibitor
Synonyms IL 23 A antibody | IL 23 antibody | IL 23 subunit alpha antibody | IL 23A antibody | IL 23p19 antibody | IL-23 subunit alpha antibody | IL-23-A antibody | IL-23p19 antibody | IL12B antibody | IL23 antibody | Il23a antibody | IL23A_HUMAN antibody | IL23P19
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity IL23A
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Interleukin-23 inhibitor
Product Description

Brazikumab (anti-IL-23) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab (anti-IL-23) can be used for the research of Crohn's disease.

Product Properties

Isotype Human IgG2
Light Chain Type lambda
SDS-PAGE 29.2 kDa (Light Chain) & 52.3 kDa (Heavy Chain), under reducing conditions; 175.4 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1610353-18-8

Associated Targets(Human)

IL23A Tclin Interleukin-23 subunit alpha (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Images

Brazikumab (anti-IL-23) (Ab175478) - SEC
The purity of Brazikumab (anti-IL-23) (Ab175478) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot Number Certificate Type Date Item
ZJ23F1202062 Certificate of Analysis Dec 20, 2023 Ab175478
ZJ23F1202063 Certificate of Analysis Dec 20, 2023 Ab175478

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.